Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Visual Function: later-stage trial registry

1 of 3 indexed Visual Function trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Visual Function: 3 US clinical trials tracked, 1 recruiting.

Visual Function is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Dr. Daniel H. Chang, MD, running 1 of these trials.

Enrollment posture brief

Registry condition visual-function

OPEN 1 | RECR 33% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Visual Function (this)33%
Open-enrollment share among volume-matched conditions near Visual Function

Visual Function lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Visual Function on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Visual Function is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Visual Function records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham/Placebo Procedure
1 trials
Cranial osteopathic manipulation Procedure
1 trials
AcrySof Natural Device
1 trials
AcrySof® Toric IOL Device
1 trials
None-placebo Other
1 trials

US sites by state

Facility locations filed on Visual Function trials. A trial with sites in several states counts in each.

Texas 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Visual Function page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Visual Function condition card totals 3 registered trials; most-linked intervention Sham/Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.